Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0YQ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,655
Award facts
- Contract value 100% obligated
- $15,654.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,654.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, issued on December 18, 2025, with completion targeted for December 19, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor providing a diverse portfolio of medications and medical supplies to defense and veteran healthcare systems. The company's extensive contract awards with DLA demonstrate its capability to supply specialty pharmaceuticals, brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains on a competitive basis. Zepbound, a GLP-1 receptor agonist indicated for weight management, represents one of numerous pharmaceutical products the company delivers through its federal contracts, supporting the Defense Health Agency and other government healthcare systems. The DLA Troop Support is planning to establish next-generation pharmaceutical prime vendor contracts with potential multiple awards across separate regions, positioning AmerisourceBergen as a key supplier within this evolving procurement strategy.
Quick answers
Who was awarded contract SPE2DR26F0YQ1?
SPE2DR26F0YQ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F0YQ1 worth?
The government has obligated $15,655 on SPE2DR26F0YQ1.
Is contract SPE2DR26F0YQ1 an order under another contract?
Yes. SPE2DR26F0YQ1 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YQ1 competed?
The extent of competition for SPE2DR26F0YQ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award